Laurion Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-290,850
| Closed | -$10.8M | – | 246 |
|
|
2024
Q2 | $10.8M | Buy |
290,850
+42,032
| +17% | +$1.56M | 0.13% | 48 |
|
|
2024
Q1 | $10.4M | Buy |
248,818
+110,287
| +80% | +$4.63M | 0.09% | 86 |
|
|
2023
Q4 | $5.49M | Buy |
+138,531
| New | +$5.49M | 0.05% | 75 |
|
|
2016
Q3 | – | Sell |
-987
| Closed | -$65K | – | 544 |
|
|
2016
Q2 | $65K | Buy |
+987
| New | +$65K | ﹤0.01% | 476 |
|
|
2015
Q3 | – | Sell |
-660
| Closed | -$250K | – | 466 |
|
|
2015
Q2 | $250K | Buy |
+660
| New | +$250K | ﹤0.01% | 263 |
|
|
2014
Q4 | – | Sell |
-1,127
| Closed | -$219K | – | 248 |
|
|
2014
Q3 | $219K | Buy |
+1,127
| New | +$219K | ﹤0.01% | 154 |
|